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Single-stranded RNA molecules fold intensively into secondary and tertiary structures and are often trapped in 
non-functional configurations. To adapt a functional configuration, structural changes have to be achieved. RNA 
helicases and RNA chaperones are proteins able to assist those structural rearrangements in an ATP-dependent 
or ATP-independent manner, respectively. The cancer-associated RNA-binding protein La (LARP3) is an RNA 
chaperone involved in various aspects of the RNA metabolism. Recently the RNA chaperone domain within the 
human La protein has been mapped and demonstrated that its activity is required to stimulate cyclin 
D1-internal ribosome entry site (IRES)-dependent protein synthesis. Furthermore, it has been shown that the La 
protein can be phosphorylated by serine/threonine kinase AKT in vitro. Taken together, we suggest a model in 
which the RNA chaperone La stimulates translation of specific target mRNAs by assisting structural changes in 
their translation start site surrounding RNA region. 
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e872. doi: 10.14800/rd.872. 
The RNA-binding protein La (LARP3, La autoantigen, 
La/SSB) [1] mainly localizes to the nucleus but shuttles to the 
cytoplasm [2-4]. The La protein (Fig. 1) contains three 
RNA-binding surfaces: the La motif (LAM) and two RNA 
recognition motifs (RRMs). The N-terminally located and 
conserved LAM is found in a variety of proteins which are 
classified as LA Related Proteins (LARPs; 
http://www.larp-society.com; [5]). The first RRM is located in 
the N-terminal domain, whereas the second RRM is located 
in the C-terminal domain and is unique to the mammalian 
version - the genuine La protein [1]. La interacts with the 
precursors of a variety of different RNA molecules e.g. 
tRNAs, mircoRNAs, snoRNAs [6-8] [9-11] and binds to long 
viral and cellular mRNAs. Besides its LAM:RRM1-mediated 
interaction with the oligo(U) 3’-termini common to nascent 
RNA polymerase III transcripts such as pre-tRNAs[12], 
human La can bind to the 5’-terminus of mRNAs referred to 
as terminal polypyrimidine tract (TOP) mRNAs[13-15], and 
internal RNA elements in RNAs such as MDM2[16], cyclin 
D1 [17], XIAP [18], human immunodeficiency virus[19], 
hepatitis C [20] and A virus [21] and polio virus [22].  
In recent years it became clear that the La protein is 
aberrantly regulated in cancerous cells. First it has been 
shown that La expression is elevated in different cancer cell 
lines as well as in chronic myelogenous leukemia, and more 
recently it has been revealed that La is overexpressed in 
various types of solid tumor tissue when compared to normal 
adjacent tissue[16, 17, 23, 24]. This finding sparked the 
interesting question whether the La protein promotes tumor 
pathogenesis when overexpressed. Recent studies have 
shown that the human La protein supports proliferation, 
migration, and invasion of cancer cells [17, 23]. The murine La 
protein has a small amino acid insertion in the C-terminal 
domain and is 7 amino acids longer than the human La. 
Experiments showed that murine La facilitates internal 
ribosome entry site (IRES)-dependent Laminin B1 mRNA 
translation and supports tumorigenesis in xenograft mouse 
models [25-27].  
REVIEW 
RNA & DISEASE 2016; 3: e872. doi: 10.14800/rd.872; © 2016 by Gunhild Sommer, et al. 
http://www.smartscitech.com/index.php/rd 
 
Page 2 of 5 
 
Those findings raised the question by which mechanism 
La facilitates tumor-promoting processes. Although the 
interaction between La and small RNA molecules, like 
pre-tRNAs, has been studied intensively, it remains to be 
demonstrated that the potential aberrant regulation of small 
RNAs by elevated La levels in cancerous cells contributes to 
tumor pathogenesis. However, La is not only implicated in 
facilitating the processing of precursor RNAs but is also 
implicated to play a role in protein synthesis. Initially, it has 
been shown that the La protein supports cap-independent 
internal ribosome entry site (IRES)-mediated translation of 
polio virus [22, 28]. Subsequently, it has been demonstrated 
that La also contributes to IRES-mediated mRNA translation 
of, hepatitis C virus [29], but on the other hand impairs 
IRES-mediated translation of hepatitis A virus [30]. Moreover, 
a growing number of reports demonstrate that the La protein 
stimulates translation of mRNAs coding for cellular proteins 
- specifically of tumor-promoting factors - allowing us to 
speculate that La, when aberrantly regulated in cancerous 
cells, contributes to tumor pathogenesis by misregulating the 
protein synthesis of critical factors such as MDM2, cyclin 
D1, XIAP, Lamimin B. However, not much is known about 
the molecular mechanism by which La facilitates or impairs 
protein synthesis. Previous work suggested that the La 
protein might facilitate 48S complex formation during 
translation initiation of polio virus and hepatitis C virus 
translation and that La might bind in close proximity to 
translation start sites [31-34]. Furthermore, earlier work 
proposed that the C-terminal domain of La is required to 
promote polio virus IRES-mediated translation [35]. Those 
studies pointed out that La might play a role in translation 
initiation of specific mRNAs. However, it is critical to 
understand the molecular mechanism in more detail to 
elucidate how La acts during translation. We started out to 
investigate whether the RNA chaperone activity of La is 
required to facilitate protein synthesis.  
It has been shown recently that La protein depletion 
causes a massive drop in cyclin D1 protein levels and 
stimulates cyclin D1 IRES-mediated translation [17]. Mapping 
the La binding site in cyclin D1 mRNA revealed that La 
binds in close proximity to the translation start site [36]. It has 
been shown earlier that the two RRMs of La are both 
required and sufficient for binding to hepatitis B virus RNA 
[21] and both RRMs are also sufficient to bind cyclin D1 
RNA[36]. Interestingly, computer calculated (mfold, [37]) 
structure of the La binding site in cyclin D1 RNA predicts a 
stem-loop structure in which the translation start site (AUG) 
is buried. We consider that the stem might impair efficient 
recognition of the AUG by the scanning 43S subunits and 
that it would beneficial for translation initiation to unwind 
the helical region. This notion triggered experiments aiming 
to demonstrate that La is actually able to assist structural 
changes in cyclin D1 mRNA-derived RNA molecules. We 
proposed that the RNA chaperone activity of La destabilizes 
the helical region and thereby easing the access of the 43S 
subunit to the AUG. To test the first part of the assumption 
an RNA chaperone assay has been developed using the La 
binding site in cyclin D1 RNA as molecular beacon 
(D1-AUG-MB). This molecular beacon has a fluorescence 
group at the 5’-end and a quencher at the 3’-end [36]. Based 
on the structural prediction of the D1-AUG-MB the 5’- and 
3’-end should be located next to each other closing the stem. 
The RNA chaperone assay bases on the assumption that if 
the La protein destabilizes the stem the fluorescence 
molecule (5’-end) would be spatially separated from the 
quencher (3’-end), allowing fluorescence light emission after 
excitation. Using the RNA chaperone assay it has recently 
been shown that recombinant human La protein can 
destabilize the helical region of the D1-AUG-MB in an 
ATP-independent manner [36]. However, the question remains 
how La is able to assist structural changes in an 
ATP-independent manner. According to a model for RNA 
chaperones [38] structural changes are first induced in the 
RNA chaperone upon RNA-binding. This structural 
rearrangement in the protein might allow additional binding 
of the RNA substrate via an auxiliary RNA-binding surface 
in the RNA chaperone. Eventually the transfer of entropy 
would facilitate structural rearrangements in the bound RNA 
[38]. The C-terminal domain of the La protein is intrinsically 
disordered (Fig. 1) and might undergo structural 
rearrangements upon binding of La to an RNA substrate [39]. 
Previous work suggested that a basic stretch of amino acids 
in the C-terminal domain might be involved in RNA-binding 
and additional work implied that the C-terminal domain is 
required for polio virus IRES-mediated translation [35, 40]. By 
introducing two sets of mutations in the C-terminal domain 
focusing on aromatic and positively charged amino acids 
known to preferentially interact with RNA, it has been 
demonstrated recently that the mutated amino acids, referred 
to as RNA chaperone domain (RCD), were critical for La to 
assist structural changes in D1-AUG-MB [36]. This finding 
suggests that RRM1 and RRM2 are required for binding of 
the D1-AUG-MB and that the RNA chaperone domain of La 
Fig 1. Comparison of human and murine La protein. LAM = La 
motif [1]; RRM = RNA Recognition motif [1]; RCD = RNA Chaperone 
domain [36]; S366 = Casein Kinase II phosphorylation site [42]; T389 = 
AKT phosphorylation site [36]; T301 = AKT phosphorylation site in 
murine La [43]. Black lines = intrinsic disordered regions [39]. 
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is required to assist structural changes in the RNA. Of note, 
this region, which is unique to mammalian La, overlaps with 
the nucleolar localization signal [41] and lays in close 
proximity to the well-established CK2 phosphorylation site 
at serine 366 [42].  
The murine La protein is phosphorylated by AKT at 
position T301 [43], which would be upstream of the potential 
RCD in murine La (Fig. 1). A genome-wide identification of 
AKT-phosphorylated proteins suggested that the La protein 
is phosphorylated by AKT at threonine 389 [44] located 
downstream of the RCD. To confirm that threonine 389 can 
be phosphorylated by AKT a La-T389A mutant has been 
created. As shown by in vitro AKT kinase assays 
recombinant La-wildtype (La-WT) but not La-T389A mutant 
protein can be phosphorylated by AKT at threonine 389 [36]. 
Next the question was asked whether phosphorylation at 
T389 might affect the RNA chaperone activity of La. 
Interestingly, native La-WT and La-T389A protein had 
comparable RNA chaperone activity. However, the RNA 
chaperone activity of phosphorylated La-WT was strongly 
impaired by AKT phosphorylation suggesting that the RNA 
chaperone activity can be regulated by phosphorylation[36]. 
Since the CK2 phosphorylation site is also located in very 
close proximity of the RCD it will be interesting to test in 
future experiments whether CK2 phosphorylation of the La 
protein has a similar effect on the RNA chaperone activity as 
AKT phosphorylation. Although phosphor-mimetic 
mutations of T389 were tested, those mutants did not display 
impaired RNA chaperone activity [36].  
According to the concept that translation start sites might 
be buried in structural elements are inefficiently recognized 
during translation initiation it has been test whether the RNA 
chaperone activity of La is critical to support translation. 
Since La regulates the cyclin D1-IRES a bi-cistronic cyclin 
D1 IRES reporter was used to test whether the RNA 
chaperone activity is required for cyclin D1-IRES-mediated 
translation in cell-based assays [36]. Interestingly, after 
transfection of capped and poly-adenylated biscitronic cyclin 
D1-IRES reporter RNA into cells expressing gfp-tagged 
La-WT or La-∆RCD (deletion mutant of RCD), it was found 
that the RNA chaperone activity is not only required to 
stimulate cyclin D1-IRES-mediated translation (firefly 
luciferase) but also cap-dependent translation of the renilla 
luciferase open reading frame [36]. Those experiments 
suggested that the RNA chaperone activity might contribute 
to the translation of several groups of mRNAs such as 
IRES-containing mRNAs or mRNAs with specific structural 
features in their 5’-UTR such as stem loops (e.g. MDM2). 
The finding that the RNA chaperone activity of La is 
required to stimulate both IRES- as well as cap-dependent 
translation raises the question about the location and the 
nature of RNA elements/structures recognized by La. It is 
possible that the chaperone activity of La has an indirect 
effect on translation by contributing to the processing of 
RNA molecules required for protein synthesis such as 
pre-tRNAs [6, 7, 45] or due to effects on microRNA processing 
[9, 10]. However, 35S-metabolic-labeling and 2D gel 
electrophoresis analysis does not suggest that La depletion 
has a global effect on protein synthesis in HeLa cells [17]. 
By testing the effect of the La-T389A mutant on 
translation of capped and poly-adenylated biscitronic cyclin 
D1-IRES reporter RNA in cell-based assays it has been 
found that threonine 389 is important to stimulate 
IRES-mediated but not cap-dependent translation [36]. This 
interesting finding suggests that AKT phosphorylation 
preferentially affects La’s ability to facilitate IRES-mediated 
translation and is not affecting to the same extend 
cap-dependent translation. However, because AKT 
phosphorylation of recombinant La impaired its RNA 
chaperone activity it was expected that La-T389A has a 
stimulating effect on the translation of transfected RNA and 
not a repressing effect. Future work will focus on solving this 
puzzling observation. Moreover, it is not known to which 
extend cellular La is phosphorylated by AKT and more work 
is required to dissect the regulation of cellular La 
functionality by AKT phosphorylation. 
Furthermore, it remains to be studied whether La assists 
structural changes in bound mRNAs in cell-based assays and 
it has to be addressed whether La, if assisting structural 
changes, would be released from the RNA. In the scenario 
that La has reduced RNA chaperone activity, due to AKT 
phosphorylation, it raises the question whether the on/off 
rates of La are affected by phosphorylation and whether La 
remains bound to an RNA substrate while unable to unwind 
the RNA structure. These are important mechanistic 
questions because if La remains bound to the RNA, another 
mechanism must exist to remove La and to facilitate 
translation initiation. Furthermore, if La releases the 
restructured RNA it is questionable whether the RNA folds 
back into its former structure or stays in the new 
conformation. The potential regulation of La’s RNA 
chaperone activity by phosphorylation might affect certain 
subsets of mRNAs, which are dependent on La-mediated 
restructuring of RNA and might slow down translation of the 
very same RNAs when the RNA chaperone activity is low 
and La is bound more tightly.  
The La protein is overexpressed in various types of tumor 
cells. AKT and CK2 kinases are both implicated in 
supporting tumor pathogenesis by affecting many cellular 
processes. Mutation of the CK2 site (S366) in human La 
revealed that rpl37 TOP mRNA was associated with fewer 
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ribosomes in LaS366A expressing cells suggesting that 
rpL37 proteins synthesis was reduced [15], Furthermore, 
mutation of the AKT site in human La impairs 
IRES-dependent cyclin D1 translation in cell-based assays, 
suggesting that both kinases might have an effect of La 
facilitated protein synthesis of specific subsets of mRNAs. 
The regulation of La’s activity by posttranslational 
modifications is probably a key aspect to understand its 
important cellular function.  
Both murine and human La is phosphorylated by AKT in 
the C-terminal domain (mouse: T301; human: T389, Fig. 1). 
Furthermore, the RNA chaperone domain and its subdomains 
(RCD1 and RCD2) are well conserved[36], suggesting that 
murine La might have a similar RNA chaperone activity 
which is regulated by AKT phosphorylation. Recently, it has 
been shown that AKT phosphorylation triggers the 
nuclear-cytoplasmic shuttling of murine La to the cytoplasm 
[43]. Mutagenesis of the murine AKT site prevented the 
nuclear export and affected translation of a number of 
mRNAs [43]. It remains to be studied whether AKT 
phosphorylation of human La is also affecting its subcellular 
distribution. 
In summary, in recent years the role of mammalian La 
protein in translation of specific mRNAs has been well 
documented. Data are accumulating that La’s activity in 
translation is regulated by phosphorylation suggesting that 
posttranslational modifications regulate La-dependent protein 
synthesis in response to activation of specific cellular 
signaling pathways. How those posttranslational 
modifications are affecting the RNA-binding activity, the 
RNA chaperone activity, and the cellular localization of 
human La remains to be determined in future studies. 
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